Searched for
DRUG PRICING POLICIES
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...- US stocks today: US market gains as semiconductor stocks rebound, Middle East tensions easeMajor Wall Street indexes saw a strong rebound. This recovery was driven by gains in chip stocks. Signs of de-escalation in Middle East ten...
- Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supplyUzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...
- Pharma exports to US seen muted this yearIndian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...
- Infosys, Tech Mahindra, TCS and other IT stocks jump up to 5%. What’s driving the rally?Indian IT stocks rose sharply on Monday, lifting the Nifty IT index nearly 3%, as investors reassessed AI-related fears, attracted by attra...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- PSU closure: Govt sets in motion new move after years wasted in stop-start processThe Centre is pushing ministries to accelerate the closure of unprofitable state-owned companies. Progress has been slow despite a policy a...
- Despite Trump's pressure, Cuba may not turn out like VenezuelaThe U.S. is increasing pressure on Cuba, but unlike Venezuela, the island nation lacks a clear opposition leader or succession plan. Cuba's...
- CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- The Iran war is now changing your Social Security check; here's the new 2027 COLA numberSocial Security COLA update 2027: Gas prices in America have surged above $4.10 per gallon, up sharply from $3.17 last year, and the impact...
- Profit on paper, loss in reality: How a routine accounting tool is used to deceive and take investors for a rideAmortisation is a number most investors skip, but it can shape reported profit. On the surface, it looks routine: A company spreads the cos...
- India losing investor attention to Asia’s AI-electronics surge, says DBS economistGlobal capital is shifting towards electronics and AI in Asia. India's foreign direct investment slowdown is not a major concern. Asia's ex...
- Hospitals warn Central Government Health Scheme reimbursement cap may hurt cancer treatmentA major private hospital group warns of a crisis for advanced cancer patients under the Central Government Health Scheme. A reimbursement c...
- Vijay sworn in as Tamil Nadu CM: Here's what TVK promised ahead of Assembly pollsTamil actor Vijay's party, Tamilaga Vettri Kazhagam, has taken charge as Tamil Nadu's new government. Vijay is now the Chief Minister. The ...
- Donald Trump's drugmaker deals may save economy $529 billion over 10 years: White HousePresident Trump's administration projects significant savings from deals with drug companies. These agreements aim to lower US prescription...
- Tamil Nadu Polls: Focus on Vijay's poll promises; TVK assured 8 gm gold for womenActor Vijay's new party TVK is poised to lead in Tamil Nadu elections. His manifesto includes significant promises like gold for marriages ...
- Thailand eyes a new rule that could change your travel plansThailand plans to implement compulsory health insurance for all foreign visitors, including tourists and workers, to mitigate unpaid medica...
- India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRIIndia is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual prop...
- AstraZeneca plans to invest $405 million in Britain, PM Keir Starmer saysPrime Minister Keir Starmer announced AstraZeneca will invest 300 million pounds in UK life sciences. This significant investment secures 1...
Load More
